IL17A and type 1 diabetes mellitus: However, if this protective effect is compromised, potentially from gut microbiome dysbiosis or pancreatic inflammation associated with T1D, the resulting gut MAIT cell populations and their IL-17 and IL-22 production may be affected and T1D onset/progression may be exacerbated.